Interestingly, previous studies have reported these genes to play important roles in cancer progression: up-regulation of EZH2 was related to poor prognosis for lung cancer patients, accompanied by potential damage of viability and migration in lung cancer cells [57]. Here, EZH2 is linked to lung carcinoma.